BMP AI Technologies Inc. (OTC: BMPA) provided a corporate update on Monday, detailing key developments during fiscal year 2025 and outlining its strategic focus areas for 2026. The company highlighted the completion of a name and ticker change to BMP AI Technologies and “BMPA,” continued SEC filings, and share cancellations to improve capital structure transparency.
A significant milestone was the removal of the Caveat Emptor designation on OTC Markets as of January 2026. The designation had been applied during the fourth quarter of 2025, and the company engaged with OTC Markets Group, submitting supplemental information to resolve the matter. The company noted that the designation materially affected market conditions, leading it to defer a previously contemplated forward stock split. However, the company stated that the split has not been abandoned and may be reconsidered based on market conditions and regulatory standing.
For 2026, BMP AI Technologies identified three strategic focus areas. The HeartEase platform, an AI-powered health diagnostics tool, will continue advancement toward commercialization, including regulatory alignment, pilot initiatives, and exploration of subscription and licensing models. The BMP Chain, an enterprise-oriented blockchain infrastructure, will see ongoing development with mainnet deployment, developer tools, and enterprise onboarding. Additionally, the company will pursue AI development and governance, focusing on ethics, compliance, and risk management frameworks.
The company emphasized disciplined execution and long-term value creation, evaluating capital requirements and financing alternatives with an eye on regulatory alignment and shareholder interests. Investors are directed to company filings with the U.S. Securities and Exchange Commission at www.sec.gov, disclosures on OTC Markets at www.otcmarkets.com, and company press releases and its website at www.bmpaitech.com for approved information.
BMP AI Technologies Inc. is a next-generation artificial intelligence and blockchain development company specializing in enterprise automation, data integrity, and decentralized business solutions. Its products include HeartEase for AI-powered health diagnostics, enterprise chatbots, and proprietary blockchain platforms for secure information distribution and internal enterprise payments.
